TIDMGSK

RNS Number : 1066C

GlaxoSmithKline PLC

14 October 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Ms E Walmsley 
===  ========================  ============================================ 
 b)   Position/status          Chief Executive Officer 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 8 October 2020 on Ordinary 
                                Shares held in the Company's Performance 
                                Share Plan subject to a 2-year holding 
                                period 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP14.2540    3,700.601 
                                               ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   N/A (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2020-10-12 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHZZLFFBBLLFBV

(END) Dow Jones Newswires

October 14, 2020 10:30 ET (14:30 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Gsk
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Gsk